{"id":3939,"date":"2018-04-18T08:11:00","date_gmt":"2018-04-18T08:11:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=3939"},"modified":"2024-05-02T11:27:44","modified_gmt":"2024-05-02T09:27:44","slug":"addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/","title":{"rendered":"Addition of granulocyte\/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial."},"content":{"rendered":"
\n

Eugeni Dom\u00e8nech<\/a> 1<\/a><\/sup>, Juli\u00e1n Pan\u00e9s<\/a> 2<\/a><\/sup>, Joaqu\u00edn Hinojosa<\/a> 3<\/a><\/sup>, Vito Annese<\/a> 4<\/a><\/sup>, Fernando Magro<\/a> 5<\/a><\/sup>, Giacomo Carlo Sturniolo<\/a> 6<\/a><\/sup>, Fabrizio Bossa<\/a> 7<\/a><\/sup>, Francisco Fern\u00e1ndez<\/a> 8<\/a><\/sup>, Benito Gonz\u00e1lez-Conde<\/a> 9<\/a><\/sup>, Valle Garc\u00eda-S\u00e1nchez<\/a> 10<\/a><\/sup>, Axel Dignass<\/a> 11<\/a><\/sup>, Jos\u00e9 Manuel Herrera<\/a> 12<\/a><\/sup>, Jos\u00e9 Luis Cabriada<\/a> 13<\/a><\/sup>, Jordi Guardiola<\/a> 14<\/a><\/sup>, Maurizio Vecchi<\/a> 15<\/a><\/sup>, Francisco Portela<\/a> 16<\/a><\/sup>, Daniel Ginard<\/a> 17<\/a><\/sup>, J Crohns Colitis. 2018 May 25;12(6):687-694.<\/p>\n<\/div>\n\n

\n

In a randomized trial, the addition of 7 weekly sessions of GMA to a conventional course of oral prednisone did not increase the proportion of steroid-free remissions in patients with active steroid-dependent UC, though it delayed clinical relapse.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/29490024\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Eugeni Dom\u00e8nech 1, Juli\u00e1n Pan\u00e9s 2, Joaqu\u00edn Hinojosa 3, Vito Annese 4, Fernando Magro 5, Giacomo Carlo Sturniolo 6, Fabrizio Bossa 7, Francisco Fern\u00e1ndez 8, Benito Gonz\u00e1lez-Conde 9, Valle Garc\u00eda-S\u00e1nchez 10, Axel Dignass 11, Jos\u00e9 Manuel Herrera 12, Jos\u00e9 Luis Cabriada 13, Jordi Guardiola 14, Maurizio Vecchi 15, Francisco Portela 16, Daniel Ginard 17, J Crohns Colitis. 2018 May 25;12(6):687-694. In a randomized trial, the addition of 7 weekly sessions of GMA to a conventional course of oral prednisone did not increase the proportion of steroid-free remissions in patients […]<\/p>\n","protected":false},"template":"","scientific_tags":[303,86,47,85,55],"class_list":["post-3939","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-combination","scientific_tags-multicentre","scientific_tags-prednisolone","scientific_tags-randomized","scientific_tags-steroid-dependent"],"acf":[],"yoast_head":"\nAddition of granulocyte\/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Addition of granulocyte\/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Eugeni Dom\u00e8nech 1, Juli\u00e1n Pan\u00e9s 2, Joaqu\u00edn Hinojosa 3, Vito Annese 4, Fernando Magro 5, Giacomo Carlo Sturniolo 6, Fabrizio Bossa 7, Francisco Fern\u00e1ndez 8, Benito Gonz\u00e1lez-Conde 9, Valle Garc\u00eda-S\u00e1nchez 10, Axel Dignass 11, Jos\u00e9 Manuel Herrera 12, Jos\u00e9 Luis Cabriada 13, Jordi Guardiola 14, Maurizio Vecchi 15, Francisco Portela 16, Daniel Ginard 17, J Crohns Colitis. 2018 May 25;12(6):687-694. In a randomized trial, the addition of 7 weekly sessions of GMA to a conventional course of oral prednisone did not increase the proportion of steroid-free remissions in patients […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T09:27:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/\",\"name\":\"Addition of granulocyte\/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2018-04-18T08:11:00+00:00\",\"dateModified\":\"2024-05-02T09:27:44+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Addition of granulocyte\/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/","og_locale":"es_ES","og_type":"article","og_title":"Addition of granulocyte\/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial. - Adacyte","og_description":"Eugeni Dom\u00e8nech 1, Juli\u00e1n Pan\u00e9s 2, Joaqu\u00edn Hinojosa 3, Vito Annese 4, Fernando Magro 5, Giacomo Carlo Sturniolo 6, Fabrizio Bossa 7, Francisco Fern\u00e1ndez 8, Benito Gonz\u00e1lez-Conde 9, Valle Garc\u00eda-S\u00e1nchez 10, Axel Dignass 11, Jos\u00e9 Manuel Herrera 12, Jos\u00e9 Luis Cabriada 13, Jordi Guardiola 14, Maurizio Vecchi 15, Francisco Portela 16, Daniel Ginard 17, J Crohns Colitis. 2018 May 25;12(6):687-694. In a randomized trial, the addition of 7 weekly sessions of GMA to a conventional course of oral prednisone did not increase the proportion of steroid-free remissions in patients […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T09:27:44+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/","name":"Addition of granulocyte\/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2018-04-18T08:11:00+00:00","dateModified":"2024-05-02T09:27:44+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/addition-of-granulocyte-monocyte-apheresis-to-oral-prednisone-for-steroid-dependent-ulcerative-colitis-a-randomized-multicentre-clinical-trial\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/3939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=3939"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=3939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}